Krishna Institute Of Medical Sciences Limited · NSE:KIMS
Krishna Institute Of Medical Sciences — Q3 FY2022 Earnings Presentation
31 slides from Krishna Institute Of Medical Sciences's earnings presentation, Feb 10, 2022
Slide 1: KIMS Hospitals – Investor presentation cover letter
KIMS HOSPITALS'" 10'h February ,2022 CIN: L55101TG1973pLC0405s8 The General Man.ager, Department of Coqporate services Listing Department Bombay Stock Exchange Ltd (BSE) National Stock Exchange of India Limited, Phroze .f heejheebho\.'forvers, lixchange Plaza, 5th F-loor, Dalal Street, Plot No,C/1,
Slide 2: Q3 FY'22
Q3 FY’22 Private & Confidential
Slide 3: Disclaimer
DISCLAIMER This presentation has been prepared by Krishna Institute of Medical Sciences Limited (“KIMS” or the “Company”) solely for your information and for your use and may not be taken away, distributed, reproduced, or redistributed or passed on, directly or indirectly, to any other person (wheth
Slide 4: Index
INDEX 1) Introduction to 2) Financial & 3) Update on 4) Update on KIMS Hospitals Operational Sunshine Hospital Expansion Plans Updates 3 Private & Confidential
Slide 5: Introduction to KIMS Hospitals
Introduction to KIMS Hospitals 4 Private & Confidential
Slide 6: KIMS at a Glance
KIMS AT A GLANCE Hyderabad Andhra Pradesh 3,666 Kondapur (200) Srikakulam (200) Secunderabad 1,904 (1000) Vizag (434) Rajahmundry (180) 1,344 1,252 Kurnool (200) Secunderabad 800 (290) (1) Ongole (350) Gachibowli (237) (2) Nellore (250) 177 Anantapur KIMS Yashoda Apollo Care AIG HCG (250) KIMS is th
Slide 7: Driven by a Vision
DRIVEN BY A VISION Affordable Quality Care Best-in-Class Facilities Patient Centric Systems & Processes S NT VISION: TIE PA To be the most preferred Clinical Outcome Driven Excellence R S healthcare services C TO Latest Medical Technology D O brand by providing Strong Academics & Research Oriented a
Slide 8: Centres of Excellence
CENTRES OF EXCELLENCE (Excluding Sunshine) Procedure Dept. Volume Technology Achievements Cardiac Sciences Angioplasty, Bypass Surgery, Cathlab • One of the largest and most experienced cardiac sciences team in South India Bentall Procedure, TAVI, EP > 2196/month Impella Device • Maximum number of B
Slide 9: Multi Specialty Care
MULTI SPECIALTY CARE Brain Eyes Bones and Spine Radiology • Neurology • Ophthalmology • Orthopedics • Imaging • Neurosurgery Gastro Intestinal Tract • Arthroscopic Surgery • Interventional Radiology • Psychiatry • Medical Gastroenterology • Spine Surgery Lab Services • Neuro Rehabilitation • Surgica
Slide 10: Modern Medical Technology
MODERN MEDICAL TECHNOLOGY 4-Arm HD da Vinci O-Arm Scanner Spy Glass Robotic Surgical Multi-dimensional surgical State of the art add on to System imaging platform optimized ERCP that allows doctors to Facilitates complex surgeries for use in spine, orthopaedic, observe patients’ biliary duct that ar
Slide 11: Corporate Structure
CORPORATE STRUCTURE Krishna Institute of Medical Sciences Ltd. KIMS Secunderabad KIMS Nellore KIMS Rajahmundry KIMS Ongole (100%) (100%) (100%) (100%) AHPL KHEPL KIMS ICON KIMS Saveera KIMS Rainbow Sarvejana Srikakulam Kondapur Vizag Anantapur Kurnool (Sunshine) (57.8%) (86.3%) (51.0%) (80.0%) (55.0
Slide 12: Shareholding Pattern - 31 December, 2021
SHAREHOLDING PATTERN - 31 DECEMBER, 2021 ST Others, 14.4% As on 31st Dec 2021 Top Shareholders - DII / FII Promoter & Promoter Foreign Portfolio Group, 38.8% Share Holder Share Holding % Category Investors, 8.7% ICICI Ventures 2.4% DII Mirae Asset MF 7.5% DII Axis MF 3.8% DII Insurance Companies, No
Slide 13: Financial and Operational Updates
Financial and Operational Updates 12 Private & Confidential
Slide 14: Financial & Operational Highlights
FINANCIAL & OPERATIONAL HIGHLIGHTS FINANCIAL Q3 FY 21-22 HIGHLIGHTS* • Consolidated operating revenue saw an increase of 10% against Q3 of FY 21, standing at Rs. 3,960 million. • Consolidated EBITDA for Q3 FY 22 stood at Rs. 1,322 million, a growth of 42% against Q3 FY 21. EBITDA margins expansion w
Slide 15: Digital & ESG Initiatives
DIGITAL & ESG INITIATIVES DIGITAL During the quarter, steady progress was made on digital transformation with notable initiatives as below: INITIATIVES • KIMS Hospitals sponsored the ‘FHIR Connectathon’ and a team of 16 members participated to build capability and show commitment to interoperability
Slide 16: Speciality, Payor & Cluster Profile
SPECIALITY, PAYOR & CLUSTER PROFILE (9M FY22) SPECIALITY MIX PAYOR MIX CLUSTER REVENUE* AP-Non Mature 20% Cardiac Science Aarogyasree Telangana 16% 9% Neuro Science 67% 11% 9M FY22 Renal Science Govt & Non Govt* Cash AP_ 9% 9% 61% Mature 13% Others Mother & Child 37% 8% Orthopaedics 5% 9M FY22 Oncol
Slide 17: Group Operating Performance 1/3
GROUP OPERATING PERFORMANCE 1/3 IP VOLUME OP VOLUME 14% 9% 36,205 36,229 261,867 280,385 279,978 31,790 32,732 256,590 28,865 31,709 23,203 181,201 182,499 130,553 Q1 FY21 Q2 FY21 Q3 FY21 Q4 FY21 Q1 FY22 Q2 FY22 Q3 FY22 Q1 FY21 Q2 FY21 Q3 FY21 Q4 FY21 Q1 FY22 Q2 FY22 Q3 FY22 FY 21 FY 22 FY 21 FY 22
Slide 18: Group Operating Performance 2/3
GROUP OPERATING PERFORMANCE 2/3 REVENUE EBITDA 10% 42% 4,775 1,479 4,171 1,428 1,342 4,112 3,960 1,322 3,608 3,627 1,051 931 2,055 401 Q1 FY21 Q2 FY21 Q3 FY21 Q4 FY21 Q1 FY22 Q2 FY22 Q3 FY22 Q1 FY21 Q2 FY21 Q3 FY21 Q4 FY21 Q1 FY22 Q2 FY22 Q3 FY22 FY 21 FY 22 FY 21 FY 22 PBT PAT 74% 76% 1,195 1,245 9
Slide 19: Group Operating Performance 3/3
GROUP OPERATING PERFORMANCE 3/3 Particulars FY19 FY20 FY21 FY22 9M Bed Capacity 2,804 3,004 3,064 3,064 Occupancy 49% 56% 58% 63% IP volume 111,382 140,676 116,592 104,143 OP volume 900,043 1,137,560 830,211 742,862 ARPOB 18,334 18,307 20,609 24,186 ARPP 81,995 79,526 113,904 123,089 ALOS 4.47 4.34
Slide 20: Comparison of Andhra Pradesh Mature & Acquired Hospitals
COMPARISON OF ANDHRA PRADESH MATURE HOSPITALS & ANDHRA PRADESH ACQUIRED HOSPITALS Matured Assets Acquired Assets Particulars Bed Capacity: FY19 FY20 FY21 9M FY22 FY19 FY20 FY21 9M FY22 New Clinical specialities of Oncology, Vascular Surgeries and Mother & Child are Bed Capacity 570 570 630 630 1034
Slide 21: Profit and Loss Statement
PROFIT AND LOSS STATEMENT (RS. MILLIONS) Particulars 9M FY 22 9M FY 21 (%) Q3 FY 22 Q2 FY 22 Q3 FY 21 QoQ(%) YoY(%) Total Income 12,905.6 9,773.8 32% 3,959.6 4,171.5 3,607.5 -5% 10% Material cost 2,800.4 2,116.4 821.8 855.2 722.6 Employee benefit expenses 1,970.6 1,638.1 610.4 635.0 619.3 Other expe
Slide 22: Key Achievements in Q3 FY22
KEY ACHIEVEMENTS IN Q3 FY22 Unique case in Asia Conducted India’s First PDA surgery was where a 12 year old First Breathing Lung done on 800 grams boy hailing from Transplant by using newly born twins Uttar Pradesh was an organ condition without open heart treated by doctors by system manufactured s
Slide 23: Key Achievements in Q3 FY22
KEY ACHIEVEMENTS IN Q3 FY22 Doctors performed Patient suffering from First left main Femoral popliteal ascending aortic bifurcation stenting bypass surgery on aneurysm and aortic was placed on a 40 68 years old patient and mitral valve years patient suffering suffering from severe diseases was treat
Slide 24: Update on Sunshine Hospital
Update on Sunshine Hospital 23 Private & Confidential
Slide 25: Sunshine Hospital - Brief Profile
SUNSHINE HOSPITAL - BRIEF PROFILE Dr. A.V. Gurava Reddy Dr. A. Bhavani Managing Director Director SECUNDERABAD GACHIBOWLI KARIMNAGAR • Started in 2009 • Locations: Secunderabad, Gachibowli & Karimnagar • Founders: Dr. A.V. Gurava Reddy & • Beds Capacity: 600+ Dr. A. Bhavani • Key Specialities: Ortho
Slide 26: Ortho Sciences - Cutting-Edge Technology at Work
ORTHO SCIENCES - CUTTING-EDGE TECHNOLOGY AT WORK • 1st Hospital in INDIA with ISOC Membership (Only 2 from India have this membership) • 4000 Total joint replacements performed on average, every year • More than 10,000 surgeries annually, across all the orthopaedic sub-specialities • More than 700 R
Slide 27: Integration Update of Sunshine Hospitals
INTEGRATION UPDATE OF SUNSHINE HOSPITALS Brand Integration: Operational Integration: Clinical Integration: • Post renovation work which is expected • IT Infrastructure updation is complete • We have identified and started work on to finish in next 2 quarters, Sunshine and the both the units are now
Slide 28: Sunshine Hospitals - Consolidated Financial Snapshot (P&L)
SUNSHINE HOSPITALS -CONSOLIDATED FINANCIAL SNAPSHOT (P&L) Ind AS P&L Summary (In INR Mn) Nov-Dec ‘21 (2 Months) Revenue (Inc. Other Income) 745.26 EBITDA 179.19 EBITDA % 24.04% Finance Cost 23.80 Depreciation 49.47 PBT 105.92 PAT 71.92 EBITDA 179.19 IND AS Adjustment 34.10 EBITDA - Pre Ind AS 145.09
Slide 29: Update on Expansion Plans
Update on Expansion Plans 28 Private & Confidential
Slide 30: Expansion Plans
EXPANSION PLANS Current Incremental New Approx. Approx. Timeline Units Beds Beds Departments Capex (Starting April 2021) Kondapur 200 500 All Specialities 300 Cr 36-42 months Vizag 434 50 Cancer Centre 15-20 Cr 24 months Cancer Centre / Anantapur 250 150 50-60 Cr 36-48 months Mother & Child Ongole 3
Slide 31: Thank You
Thank You 30 Private & Confidential
Krishna Institute of Medical Sciences — Q3 FY2022 Earnings Presentation on 6ix